Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews · Musculoskeletal

No studies found 3 · 60%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 40%Moderate 0 · 0%High 0 · 0%

Pain (0‐10 cm visual analog scale)‐ Pain at 6‐12 weeks Visual Analog or Verbal Rating Scale. Scale from: 0 to 10. ( · patients with shoulder pain

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 76 participants
Low

Number of Adverse Events (AEs) ( · patients with shoulder pain

The intervention showed no clear difference in number of Adverse Events (AEs) ( (low certainty).

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
RR 1.46 [0.64, 3.36]
3 studies · 65 participants
Low

Disability/function ‐ not reported · patients with shoulder pain

The review found no eligible studies for this question.

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

WIthdrawals due to Adverse Events ‐ not reported · patients with shoulder pain

The review found no eligible studies for this question.

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Serious Adverse Events ‐ not reported · patients with shoulder pain

The review found no eligible studies for this question.

1 finding from 1 review

Botulinum toxin for shoulder pain 2010 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found